Angela Borghouts - de Ruijter | Associate Director Market Access
Gilead Sciences

Angela Borghouts - de Ruijter, Associate Director Market Access, Gilead Sciences

Trained as a Pharmacist. Holds an additional master's degree in health economics. Works within market access for 6 years now. Previously worked for Novartis, covering multiple therapeutic areas: neurological-, dermatologic-, respiratory- and cardiac diseases. Working at Gilead Kite for almost 3 years now, covering the field of CAR-T/ Cell therapy. Next to addressing and discussing access issues and solutions, she is putting sustainability higher on the agenda.

Appearances:



Day 1 - Tuesday 28 October @ 16:10

Reimbursement timelines and key access challenges for Cell & Gene therapies in the Netherlands vs other EU countries

last published: 23/Oct/25 22:05 GMT

back to speakers

Get involved at World Orphan Drug Congress Europe 2025

 

 

TO SPONSOR


Steph Scanlon

Steph.Scanlon@terrapinn.com

 

TO SPEAK


Abdu Kauroo
Abdu.Kauroo@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.